Person looking at computer screen

Emerging Markets Equity Fund

  • Vehicle UCITS
  • Asset Class Equities

Overview

The GMO Emerging Markets Equity Fund seeks to generate total return in excess of that of its benchmark, the MSCI Emerging Markets Index.
The Fund is distinguished by an emphasis on both top-down country-sector allocation and value. The Emerging Markets Equity team believes that getting macroeconomic perspectives right in emerging equity markets is most important and that value wins over the long term. The team applies both quantitative and fundamental insights to evaluate countries, sectors, and stocks, using an investment process focused on value and also informed by quality and sentiment inputs. 
 

Facts

Doc Table
Fund Inception Date May 16, 2002
Fund Total Assets as of 8/31/2019 $143mm USD
SEDOL 3184116
ISIN IE0031841160
Benchmark MSCI Emerging Markets
NAV as of 9/17/2019 37.92

Performance

Quarter-End as of June 30, 2019(USD, %)

Table Caption
QTD YTD 1-Year 3-Year 5-Year 10-Year ITD
Emerging Markets Equity Fund 2.57 12.17 5.85 10.70 2.28 5.23 8.16
MSCI Emerging Markets 0.61 10.59 1.21 10.67 2.49 5.81 9.11
  • Emerging Markets Equity Fund 1
  • MSCI Emerging Markets

Inception Date: May 16, 2002

Returns shown for periods greater than one year are on an annualized basis.

Net of all fees and expenses after reimbursement by the Manager, but not transaction costs, if any. If certain expenses were not reimbursed, performance would be lower.

Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein.

1 As of January 1, 2019, the Emerging Markets Equity Fund changed its benchmark so that the Fund now seeks total return in excess of that of the MSCI Emerging Markets Index. The Fund formerly sought to outperform the S&P/IFCI Composite Index.

Quarter-End as of June 30, 2019(USD, %)

Table Caption
QTD YTD 1-Year 3-Year 5-Year 10-Year ITD
Emerging Markets Equity Fund 2.82 12.75 6.98 11.96 3.47 6.49 9.52
MSCI Emerging Markets 0.61 10.59 1.21 10.67 2.49 5.81 9.11
  • Emerging Markets Equity Fund 1
  • MSCI Emerging Markets

Inception Date: May 16, 2002

Returns shown for periods greater than one year are on an annualized basis.

Gross of fees, expenses and transaction costs, if any. If these fees, expenses and costs were included, performance would be lower.

Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein.

1 As of January 1, 2019, the Emerging Markets Equity Fund changed its benchmark so that the Fund now seeks total return in excess of that of the MSCI Emerging Markets Index. The Fund formerly sought to outperform the S&P/IFCI Composite Index.

Month-End as of August 31, 2019(USD, %)

Table Caption
MTD QTD YTD 1-Year 3-Year 5-Year 10-Year ITD
Emerging Markets Equity Fund -6.70 -6.29 5.12 -0.61 5.38 0.41 3.24 7.67
MSCI Emerging Markets -4.88 -6.04 3.92 -4.36 5.76 0.38 3.93 8.63
  • Emerging Markets Equity Fund 1
  • MSCI Emerging Markets

Inception Date: May 16, 2002

Returns shown for periods greater than one year are on an annualized basis.

Net of all fees and expenses after reimbursement by the Manager, but not transaction costs, if any. If certain expenses were not reimbursed, performance would be lower.

Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein.

1 As of January 1, 2019, the Emerging Markets Equity Fund changed its benchmark so that the Fund now seeks total return in excess of that of the MSCI Emerging Markets Index. The Fund formerly sought to outperform the S&P/IFCI Composite Index.

Month-End as of August 31, 2019(USD, %)

Table Caption
MTD QTD YTD 1-Year 3-Year 5-Year 10-Year ITD
Emerging Markets Equity Fund -6.62 -6.12 5.85 0.45 6.57 1.58 4.46 9.02
MSCI Emerging Markets -4.88 -6.04 3.92 -4.36 5.76 0.38 3.93 8.63
  • Emerging Markets Equity Fund 1
  • MSCI Emerging Markets

Inception Date: May 16, 2002

Returns shown for periods greater than one year are on an annualized basis.

Gross of fees, expenses and transaction costs, if any. If these fees, expenses and costs were included, performance would be lower.

Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein.

1 As of January 1, 2019, the Emerging Markets Equity Fund changed its benchmark so that the Fund now seeks total return in excess of that of the MSCI Emerging Markets Index. The Fund formerly sought to outperform the S&P/IFCI Composite Index.

Year Ending December 31 (USD, %)

Calendar
Emerging Markets Equity Fund MSCI Emerging Markets
2018 -11.93 -14.58
2017 31.05 37.28
2016 16.16 11.19
2015 -16.54 -14.92
2014 -6.61 -2.19
2013 -4.82 -2.60
2012 14.68 18.22
2011 -16.94 -18.42
2010 19.63 18.88
2009 71.60 78.51
  • Emerging Markets Equity Fund 1
  • MSCI Emerging Markets

Inception Date: May 16, 2002

Returns shown for periods greater than one year are on an annualized basis.

Net of all fees and expenses after reimbursement by the Manager, but not transaction costs, if any. If certain expenses were not reimbursed, performance would be lower.

Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein.

1 As of January 1, 2019, the Emerging Markets Equity Fund changed its benchmark so that the Fund now seeks total return in excess of that of the MSCI Emerging Markets Index. The Fund formerly sought to outperform the S&P/IFCI Composite Index.

Year Ending December 31 (USD, %)

Calendar
Emerging Markets Equity Fund MSCI Emerging Markets
2018 -10.92 -14.58
2017 32.55 37.28
2016 17.55 11.19
2015 -15.53 -14.92
2014 -5.50 -2.19
2013 -3.62 -2.60
2012 16.03 18.22
2011 -15.92 -18.42
2010 21.09 18.88
2009 73.75 78.51
  • Emerging Markets Equity Fund 1
  • MSCI Emerging Markets

Inception Date: May 16, 2002

Returns shown for periods greater than one year are on an annualized basis.

Gross of fees, expenses and transaction costs, if any. If these fees, expenses and costs were included, performance would be lower.

Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein.

1 As of January 1, 2019, the Emerging Markets Equity Fund changed its benchmark so that the Fund now seeks total return in excess of that of the MSCI Emerging Markets Index. The Fund formerly sought to outperform the S&P/IFCI Composite Index.

Management

Chiang_Warren

Warren Chiang

Head of Quantitative, Emerging Markets Equity

Mr. Chiang is a portfolio manager for GMO’s Emerging Markets Equity team and oversees quantitative research. Prior to joining GMO in 2015, he worked at Mellon Capital Management as a Managing Director of Active Equity Strategies. Previously, he worked at the Federal Reserve Bank of San Francisco as a research associate. Mr. Chiang earned his B.A. in Economics and his MBA from the University of California Berkeley. He is a CFA charterholder.

Bhartia_Amit

Amit Bhartia

Head of Fundamental, Emerging Markets Equity

Mr. Bhartia is a portfolio manager for GMO’s Emerging Markets Equity team and oversees fundamental research. Additionally, he serves as CEO and an executive director of GMO Singapore Pte Ltd. Prior to joining GMO in 1995, he worked as an investment advisor in India. Mr. Bhartia earned a Bachelor of Engineering at the University of Bombay and an MBA at the Institute for Technology and Management in Bombay. He is a CFA charterholder.

Divecha_Arjun

Arjun Divecha

Head of Emerging Markets Equity

Mr. Divecha is the head of GMO’s Emerging Markets Equity team and a member of the GMO Board of Directors. Prior to joining GMO in 1993, he spent 12 years at BARRA directing software development, marketing, client service and emerging markets research and development. Mr. Divecha holds a Bachelor of Technology in Aeronautical Engineering from the Indian Institute of Technology, Bombay and an M.B.A. in Finance from Cornell University.

Documents

Literature

Fact Sheet
Memorandum of Association of GMO Funds Plc
Prospectus
KIID
Download All

Downloads

Performance
Portfolio Composition
Holdings
Download All

Commentary & Attribution

Commentary - Monthly
Commentary - Quarterly
Attribution - Monthly
Attribution - Quarterly
Attribution - YTD
Download All

Investor Information

Annual Report
Semiannual Report
NAVs and Distributions
Fair Value Hierarchy
Download All

Risks

Risks associated with investing in the Fund may include Market Risk - Equities, Non-U.S. Investment Risk, Currency Risk, Management and Operational Risk, and Illiquidity Risk. For a more complete discussion of these risks and others, please consult the Fund's prospectus.

Disclosures

The making available of any document on this website does not constitute a promotion, offer or sale of any securities, financial instruments, or other financial products to the public in or into any jurisdiction where such promotion, offer or sale is prohibited or to any person or class of person to whom such securities or financial instruments may not be lawfully promoted, offered or sold. You should not rely on any document on this website in making any decision to engage in investment activity without seeking further information from GMO to enable GMO to determine whether you may be eligible to receive such further information or purchase or subscribe for any securities or other financial instruments.

Back to top